BNP PA CT/OPEN/ Stock

Certificat

EG7MB

NLBNPNL2MVM6

Market Closed - Euronext Paris 12:30:01 2024-05-20 pm EDT
5.235 EUR -0.57% Intraday chart for BNP PA CT/OPEN/
Current month-53.69%
1 month-53.96%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-20 5.235 -0.57%
24-05-17 5.265 +3.54%
24-05-16 5.085 +2.11%
24-05-15 4.98 -12.09%
24-05-14 5.665 +1.34%

Real-time Euronext Paris

Last update May 20, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
EG7MB
ISINNLBNPNL2MVM6
Date issued 2024-01-30
Maturity Unlimited
Parity 1 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.85
Lowest since issue 4.94
Spread 0.05
Spread %0.95%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.53 USD
Average target price
31.94 USD
Spread / Average Target
+11.95%
Consensus
  1. Stock Market
  2. Certificates
  3. EG7MB Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW